Cyclophosphamide treatment of mouse systemic lupus erythematosus.
D000686:Amyloidosis / Q000473:pathology; D000743:Anemia, Hemolytic / Q000188:drug therapy; D000818:Animals; D000974:Antibodies, Antinuclear; D003520:Cyclophosphamide / Q000627:therapeutic use*; D005260:Female; D005921:Glomerulonephritis / Q000188:drug therapy / Q000473:pathology; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007178:Inbreeding; D008107:Liver Diseases / Q000473:pathology; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy* / Q000662:veterinary; D008297:Male; D051379:Mice; D009392:Nephrectomy; D011507:Proteinuria / Q000209:etiology; D012376:Rodent Diseases / Q000188:drug therapy; D013158:Splenic Diseases / Q000473:pathology; D014511:Uremia / Q000517:prevention & control; D005719:gamma-Globulins / Q000032:analysis
D000974:Antibodies, Antinuclear; D007166:Immunosuppressive Agents; D005719:gamma-Globulins; D003520:Cyclophosphamide